Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0602 CHF | -7.38% | +2.03% | +30.87% |
Jun. 06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
Jun. 06 | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.87% | 6.59M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ADXN Stock
- News Addex Therapeutics Ltd
- HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating